CIK 0000883984 · Large accelerated filer
ICU MEDICAL INC/DE
Sign in to watch- Ticker
- ICUI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330022692
- Phone
- 949-366-2183
- Business address
- 951 CALLE AMANECER, SAN CLEMENTE, CA, 92763-6212
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,543,969
- in 3 filings, $3.5M under 10b5-1 plans
Net −$3,543,969. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-01 | Woolson Daniel VP, GM-Infusion Capital | Sale | −1,729 | $88.03 | $152K | 9,877 |
| 2023-09-08 | Voigtlander Christian B. Chief Operating Officer | Sale | −6,162 | $128.97 | $795K | 14,291 |
| 2023-09-08 | Voigtlander Christian B. Chief Operating Officer | Sale | −688 | $129.64 | $89K | 13,603 |
| 2023-07-12 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +30,000 | $58.79 | $1.8M | 53,677 |
| 2023-07-12 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −30,000 | $180.02 | $5.4M | 23,677 |
| 2023-07-12 | Jain Vivek Chairman and CEO | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −30,000 | 146,366 | ||
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +6,712 | $58.79 | $395K | 30,389 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −6,712 | $185.73 | $1.2M | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +3,637 | $58.79 | $214K | 27,314 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −3,637 | $186.50 | $678K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +2,781 | $58.79 | $163K | 26,458 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −2,781 | $187.43 | $521K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +8,163 | $58.79 | $480K | 31,840 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −8,163 | $188.52 | $1.5M | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +785 | $58.79 | $46K | 24,462 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −785 | $189.32 | $149K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +1,699 | $58.79 | $100K | 25,376 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,699 | $190.48 | $324K | 23,677 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Option exercise 10b5-1 | +1,601 | $58.79 | $94K | 25,278 |
| 2023-06-14 | Jain Vivek Chairman and CEO | Sale 10b5-1 | −1,601 | $192.06 | $307K | 23,677 |
Page 21 of 44 · 868 trades